Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Hanger : Announces Date of 2021 Third Quarter Earnings Release and Conference Call

10/11/2021 | 04:11pm EST

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the third quarter and nine months ended September 30, 2021 after the stock market closes on Monday, November 8, 2021.

Hanger's management team will host a conference call with the financial community to discuss the financial results the following morning on Tuesday, November 9 at 8:30 a.m. Eastern time.

A live webcast, replay of the call and earnings release, will be available on the Company's Investor Relations website: investor.hanger.com.

For members of the financial community participating in the conference call: dial 844-200-6205, or 929-526-1599 outside the U.S. and Canada, Access code is 409299.

About Hanger, Inc. – Headquartered in Austin, Texas, Hanger, Inc. (NYSE: HNGR) provides comprehensive, outcomes-based orthotic and prosthetic (O&P) services through its Patient Care segment, with approximately 800 Hanger Clinic locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. Recognized by Forbes as one of America’s Best Employers for 2021, and rooted in 160 years of clinical excellence and innovation, Hanger is a purpose-driven company with a vision to lead the O&P markets by providing superior patient care, outcomes, services and value, aimed at empowering human potential. For more information on Hanger, visit investor.hanger.com.

This press release contains statements that are forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include information concerning our liquidity and our possible or assumed future results of operations, including descriptions of our business strategies. These statements often include words such as “believe,” “expect,” “project,” “potential,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “would,” “should,” “could,” “forecasts” or similar words. These statements are based on certain assumptions that we have made in light of our experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. We believe these assumptions are reasonable, but you should understand that these statements are not guarantees of performance or results, and our actual results could differ materially from those expressed in the forward-looking statements due to a variety of important factors, both positive and negative, that may be revised or supplemented in subsequent releases or reports. These statements involve risks, estimates, assumptions, and uncertainties that could cause actual results to differ materially from those expressed in these statements and elsewhere in this release. These uncertainties include, but are not limited to, the financial and business impacts of COVID-19 on our operations and the operations of our customers, suppliers, governmental and private payers and others in the healthcare industry and beyond; federal laws governing the health care industry; governmental policies affecting O&P operations, including with respect to reimbursement; failure to successfully implement a new enterprise resource planning system or other disruptions to information technology systems; the inability to successfully execute our acquisition strategy, including integration of recently acquired O&P clinics into our existing business; changes in the demand for our O&P products and services, including additional competition in the O&P services market; disruptions to our supply chain; our ability to enter into and derive benefits from managed-care contracts; our ability to successfully attract and retain qualified O&P clinicians; and other risks and uncertainties generally affecting the health care industry. For additional information and risk factors that could affect the Company, see its Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission. The information contained in this press release is made only as of the date hereof, even if subsequently made available by the Company on its website or otherwise.

ę Business Wire 2021
All news about HANGER, INC.
11/29HANGER, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial ..
11/16Weatherford International Secures Two Contracts Valued at More Than $1 Billion from Abu..
11/16Weatherford International Gets Two Five-Year Contracts From Abu Dhabi National Oil
11/09HANGER, INC. Results of Operations and Financial Condition (form 8-K/A)
11/09Hanger, Inc. acquired 4 Additional Independent O&P Clinic Businesses in Minnesota, Mont..
11/08HANGER : Q3 Earnings Snapshot
11/08Hanger Reports Third Quarter 2021 Financial Results - Form 8-K
11/08HANGER, INC. : Results of Operations and Financial Condition (form 8-K)
11/08Hanger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septe..
More news
Financials (USD)
Sales 2021 1 132 M - -
Net income 2021 41,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 16,2x
Yield 2021 -
Capitalization 660 M 660 M -
Capi. / Sales 2021 0,58x
Capi. / Sales 2022 0,55x
Nbr of Employees 4 700
Free-Float 94,3%
Duration : Period :
Hanger, Inc. Technical Analysis Chart | HNGR | US41043F2083 | MarketScreener
Technical analysis trends HANGER, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 2
Last Close Price 17,05 $
Average target price 29,00 $
Spread / Average Target 70,1%
EPS Revisions
Managers and Directors
Vinit K. Asar President, Chief Executive Officer & Director
Thomas E. Kiraly Chief Financial Officer & Executive Vice President
Christopher B. Begley Non-Executive Chairman
C. Scott Ranson Chief Information Officer & EVP-Corporate Services
James H. Campbell Chief Clinical Officer & Senior Vice President
Sector and Competitors